Literature DB >> 32031275

Patient satisfaction with a new skin cancer teledermatology service.

P Nicholson1, C Macedo1, C Fuller1, L Thomas1.   

Abstract

BACKGROUND: Rising numbers of two-week-wait (2WW) skin cancer referrals have caused increasing pressure on UK dermatology departments. Initiatives to address this include teledermatology. Previous studies have indicated good patient acceptability but most have focused on general dermatology rather than skin cancer referrals, and have taken place in rural settings, where teledermatology may be preferable. AIM: To evaluate patient satisfaction of teledermatology 2WW services in a London-based tertiary National Health Service (NHS) setting.
METHODS: A literature search was performed and a patient satisfaction survey was designed to evaluate: (i) ease of completing a questionnaire about the skin lesion; (ii) lifestyle impact; (iii) preferences regarding electronic data collection and communication of results; and (iv) confidence in the service. A five-point Likert scale was used to assess responses. The study took place over a 20-week period.
RESULTS: Over half (51%; n = 31 of 60 patients) were female; 78% (47) were aged ≤ 55 years and 65% (39) were Caucasian. Over 80% (49) would recommend the service, and the majority felt confident with the teledermatology model. Overall, patients would be happy to complete electronic questionnaires and receive results electronically, with younger patients being more amenable to this. Patients with better health status, those of younger age and those with less frequent visits to a dermatologist were more accepting of teledermatology.
CONCLUSION: To our knowledge, this is the first comprehensive study evaluating patient satisfaction with teledermatology specifically for 2WW referrals in an NHS setting. As skin cancer referrals increase, dermatology departments must adjust. Patient involvement and feedback is paramount in implementing and expanding teledermatology services.
© 2020 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2020        PMID: 32031275     DOI: 10.1111/ced.14191

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  6 in total

Review 1.  Implementation of a telemedicine service to provide skin cancer care in a tertiary plastic surgery unit during COVID-19 - a comprehensive review.

Authors:  Molly Jakeman; Rong Khaw; Shomari Zack-Williams; Philip Brackley
Journal:  J Plast Reconstr Aesthet Surg       Date:  2022-04-25       Impact factor: 3.022

Review 2.  Teledermatology During COVID-19: An Updated Review.

Authors:  Morgan A Farr; Madeleine Duvic; Tejas P Joshi
Journal:  Am J Clin Dermatol       Date:  2021-04-09       Impact factor: 6.233

3.  Teledermatology in Times of COVID-19 Confinement: Comparing Patients' and Physicians' Satisfaction by the Standardized Brest Teledermatology Questionnaire.

Authors:  Joachim W Fluhr; Annie Gueguen; Delphine Legoupil; Emilie Brenaut; Claire Abasq; Helena Araújo; Laurent Misery
Journal:  Dermatology       Date:  2021-02-10       Impact factor: 5.366

Review 4.  Interventions to improve early cancer diagnosis of symptomatic individuals: a scoping review.

Authors:  George N Okoli; Otto L T Lam; Viraj K Reddy; Leslie Copstein; Nicole Askin; Anubha Prashad; Jennifer Stiff; Satya Rashi Khare; Robyn Leonard; Wasifa Zarin; Andrea C Tricco; Ahmed M Abou-Setta
Journal:  BMJ Open       Date:  2021-11-09       Impact factor: 2.692

5.  Factors influencing use and perceptions of teledermatology: A mixed-methods study of 942 participants.

Authors:  Ellie Ci-En Choi; Li Wei Heng; Sean Yilong Tan; Phillip Phan; Nisha Suyien Chandran
Journal:  JAAD Int       Date:  2022-02-01

Review 6.  Teledermatology: current indications and considerations for future use.

Authors:  Jacob Beer; Edward Hadeler; Alejo Calume; Howard Gitlow; Keyvan Nouri
Journal:  Arch Dermatol Res       Date:  2020-10-19       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.